Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who were born female and are not yet through menopause, between the ages of 18 and 50
- Men who were born male, between the ages of 18 and 50
- People who have been diagnosed with migraines (based on standard medical guidelines known as ICHD-3)
- People who have been identified as either responding well or not responding well to a type of migraine medication called triptans (based on specific research criteria)
- People who use triptans on their own or alongside other migraine treatments, such as anti-inflammatory painkillers, acetaminophen, ergotamine, opioids, or anti-nausea medications
- Any dose or method of taking these medications is acceptable (for example, tablets, injections, or nasal sprays)
- People who are part of a social security or public health insurance system
Who may not be able to join:
- People who are under legal guardianship, court-appointed protection, or who have had their personal freedoms restricted in any legal way (confirm with trial site)
- Women who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xavier Moisset, University Hospital, Clermont-Ferrand
Phone: 0033473754027
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Plasma tryptophan levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.